Acorda Therapeutics, Inc.
ACOR · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $38 | $46 | $71 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $17 | $14 | $17 | $20 |
| Inventory | $16 | $13 | $19 | $29 |
| Other Curr. Assets | $11 | $18 | $21 | $101 |
| Total Curr. Assets | $75 | $82 | $102 | $221 |
| Property Plant & Equip (Net) | $6 | $8 | $11 | $26 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $23 | $305 | $336 | $367 |
| Long-Term Investments | $0 | $0 | $6 | $19 |
| Tax Assets | $9 | $43 | $82 | $87 |
| Other NC Assets | $4 | -$43 | -$82 | -$87 |
| Total NC Assets | $43 | $313 | $353 | $411 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $118 | $396 | $455 | $633 |
| Liabilities | – | – | – | – |
| Payables | $15 | $10 | $12 | $14 |
| Short-Term Debt | $188 | $2 | $8 | $77 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $28 | $0 |
| Other Curr. Liab. | $26 | $26 | $6 | $10 |
| Total Curr. Liab. | $228 | $38 | $54 | $137 |
| LT Debt | $3 | $171 | $183 | $183 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $9 | $44 | $14 | $19 |
| Other NC Liab. | $36 | $48 | $54 | $54 |
| Total NC Liab. | $48 | $264 | $250 | $257 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $276 | $302 | $304 | $395 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,189 | -$936 | -$870 | -$766 |
| AOCI | $1 | $1 | -$1 | -$3 |
| Other Equity | $1,030 | $1,029 | $1,022 | $1,007 |
| Total Equity | -$158 | $94 | $151 | $238 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $118 | $396 | $455 | $633 |
| Net Debt | $161 | $135 | $145 | $189 |